BIOVERATIV Trademark

Trademark Overview

On Tuesday, July 26, 2016, a trademark application was filed for BIOVERATIV with the United States Patent and Trademark Office. The USPTO has given the BIOVERATIV trademark a serial number of 87116555. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, January 12, 2024. This trademark is owned by Biogen Hemophilia Inc.. The BIOVERATIV trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
bioverativ

General Information

Serial Number87116555
Word MarkBIOVERATIV
Filing DateTuesday, July 26, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, January 12, 2024
Registration Number5318162
Registration DateTuesday, October 24, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Pseudo MarkBIO VERATIV
Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 29, 2016
Primary Code042
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History

Party NameBIOVERATIV THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451
Party NameBIOVERATIV THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451
Party NameBIOVERATIV THERAPEUTICS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameBiogen Hemophilia Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, January 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, January 12, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, January 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 30, 2023TEAS SECTION 8 RECEIVED
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Friday, September 22, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 21, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 19, 2017ASSIGNED TO EXAMINER
Friday, September 1, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, August 14, 2017USE AMENDMENT FILED
Friday, September 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 14, 2017TEAS STATEMENT OF USE RECEIVED
Friday, April 14, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 14, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 14, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 14, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 4, 2016ASSIGNED TO EXAMINER
Wednesday, September 28, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 30, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, July 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 29, 2016NEW APPLICATION ENTERED

Related Keywords

bioverativ services development drug pharmaceutical